A 54-year-old woman presented with intractable perianal, bilateral buttock, and radiating thigh/calf pain. An MRI scan showed an intradural, contrast-enhancing, ovoid mass in the cauda equina region at L1-L2. At laminectomy, the ovoid mass arose from a nerve root and, intact, was gross totally resected. Histologically, the dominant pattern was that of schwannoma. One year thereafter, the symptoms recurred. An MRI scan demonstrated an irregular, heterogeneously enhancing tumor recurrence. A repeat laminectomy disclosed a large fleshy tumor involving multiple nerve roots. The lesion was subtotally resected and showed pluridirectional differentiation toward embryonal rhabdomyosarcoma, primitive neuroectodermal tumor, and rare malignant epithelial cells. Review of the original tumor disclosed only foci of embryonal rhabdomyosarcoma and primitive neuroectodermal tumor. Based upon available data regarding divergent differentiation in peripheral nerve sheath tumors, this is a unique, previously undescribed tumor demonstrating rhabdomyosarcomatous, primitive neuroectodermal tumor and scant epithelial differentiation in a schwannoma. In essence, it is a variant of malignant Triton tumor because of its origin in a tumor consisting of well-differentiated Schwann cells. It supports the contention that the Schwann cell is the source of a variety of heterologous elements in nerve sheath tumors.
Divergent differentiation in nerve sheath tumors most often takes the form of rhabdomyosarcoma within the substance of a malignant peripheral nerve sheath tumor (MPNST). Such lesions are termed malignant Triton tumors, 25, 27 referring to the studies of Masson who postulated that divergent myoid differentiation could occur in neoplastic neuroectodermal cells. 15, 16 In approximately 15% of cases, osseous and/or cartilaginous elements or even a variety of epithelia may be observed (pluridirectional differentiation). 6 The process is not limited to MPNST. Histologically benign striated muscle differentiation has also been reported in a neurofibroma of the vagina. 1 Herein, we report a unique example of schwannoma undergoing transformation to embryonal rhabdomyosarcoma in addition to primitive neuroectodermal tumor (PNET) cells and cells with an epithelial immunophenotype (pluridirectional differentiation). The finding underscores the differentiating potential of neoplastic Schwann cells and indirectly confirms the schwannian origin of heterologous differentiation in MPNST and rarely neurofibroma. 4, 30 
CASE REPORT
The patient, a 54-year-old white woman, presented with a 7-day history of intermittent perirectal and bilateral buttocks pain that was sharp in nature and exacerbated with movement. On the day prior to emergency admission, the pain became intense and radiated down both legs to the level of the ankle. The patient was ambulatory at the time of admission. Despite a 10-mg injection of intramuscular morphine, no pain relief was noted. She remained supine and strictly avoided movement. A clinical history indicated she was married, the mother of two children, and a nonsmoker. The family history was noncontributory; her mother had died of cancer secondarily involving bone and her father of Parkinson disease. A brother was alive and well. There was no family history of central nervous system neoplasia or of neurofibromatosis types 1 or 2. A general, some-what limited physical examination was unrevealing. Vital signs were normal, and there were no cardiorespiratory symptoms, organomegaly, adenopathy, or masses involving rectal/perirectal soft tissue. A neurologic examination, again limited, revealed no abnormality. The MRI examination demonstrated a large, intradural extramedullary mass in the spinal canal in the region of the cauda equina just distal to the conus at L2-L3 (Fig. 1A) . The mass had nonspecific signal characteristics with low signal intensity on T1, primarily high signal on T2, and diffuse enhancement with gadolinium. There was a central focus of low signal intensity on the T2 and gadolinium-enhanced images. The differential diagnosis for a mass in this anatomic location with these imaging features would include schwannoma, meningioma, ependymoma, and metastatic disease. The central focus of low signal intensity seen within this hyperintense lesion on the T2-weighted images has been described as a characteristic MRI feature of neurilemmoma or neurofibroma, indicating that this could represent a schwannoma.
At surgery, an L1-L2 laminectomy, no abnormalities of bone or the epidural space were noted. Upon opening the dura, intradural adhesions were evident and required lysis. The tumor, an ovoid, smooth-surfaced mass, was seen to arise from a nerve root, which was splayed over its surface. The involved nerve was divided proximally and distally. The lesion was delivered intact. Fourteen months thereafter, the patient presented after a 2-week history of severe, intractable, low back pain worsened by movement. Increasing leg weakness was evident, but no abnormalities of bowel or bladder function were noted. The follow-up MRI demonstrated a recurrent ovoid mass in the operative bed of the previously resected lesion (Fig. 1B) . The mass had similar signal characteristics with low signal intensity on T1 and high signal intensity on T2. However, the mass was slightly larger in size than the previous mass and demonstrated an increase in lesion heterogeneity and margin irregularity on the T2-weighted and gadoliniumenhanced images, features suggestive of a malignant lesion or malignant degeneration of a previously benign tumor. At surgery, again an L1-L2 laminectomy, a yellow-gray tumor bulged from the dural incision. A gross total removal of tumor lying between levels L1 and 2 was achieved.
FIG. 1.
Sagittal T1-weighted images with fat saturation and gadolinium (A) demonstrate a large well-circumscribed intradural extramedullary mass in the spinal canal just distal to the conus in the region of the cauda equina at L2-L3. There is a small central focus of low signal intensity within the hyperintense lesion on the gadolinium-enhanced image. The recurrence on sagittal T1-weighted images with fat saturation and gadolinium enhancement (B) obtained 14 months following resection of the primary tumor shown in A shows a recurrent mass with similar signal characteristics and anatomic location. The recurrent mass is slightly larger in size and demonstrates an increase in lesion heterogeneity and margin irregularity.
MATERIALS AND METHODS
Both specimens were fixed in 10% buffered formalin, routinely processed, sectioned at 5 m, and stained by the hematoxylin and eosin method. Using the avidin biotin peroxidase complex method, antisera directed to the following were applied: S-100 protein (Dako Corp, Carpinteria, CA, USA; polyclonal dilution 1:800), epithelial membrane antigen (Dako Corp; monolconal E29, 
RESULTS
The primary tumor, particularly at low power magnification, showed all of the characteristic features of schwannoma, including a thick collagenous capsule, an attenuated nerve fascicle on its surface, hyalinized vessels, an admixture of compact Antoni A tissue featuring the formation of occasional nodules and Verocay bodies, as well as Antoni B tissue (Fig 2A) . MIB-1 staining in this component was essentially 0. At higher power (Fig.  2B) , cytologically malignant cells were present singly and in loose clusters often accompanied by a somewhat mucoid matrix. Approximately 50% of this tumor component showed MIB-1 immunoreactivity. The cells varied from uninucleate to multinucleate, were hyperchromatic and irregular in configuration, and featured frequent mitoses, some abnormal. Cytoplasm varied in quantity from scant to moderate, being pale to amphophilic. Myotubes and cross-striations were not observed. The neoplastic Schwann cells of the schwannoma component showed strong uniform immunoreactivity for S-100 protein and membranous staining for collagen 4. Neurofilament protein immunoreactivity was limited to the nerve fascicle on the tumor surface and to nerve fibers within a minor portion of the tumor. Epithelial membrane antigen staining was limited to perineurial cells of the fascicle and in the tumor capsule. Scattered weak to moderately p53-immunoreactive nuclei were noted within the Schwann cell component. Three myoid markers (desmin, myogenin, and MYO D1) showed no reactivity within the Schwann cells; the same was true of synaptophysin, keratin (AE1 AE3; CAM5.2), and CD99. In contrast, the scattered cytologically malignant cells showed variable but strong reactivity for all three myoid markers, as well as for synaptophysin. No staining was seen for CAM5.2, keratin (AE1-AE3), epithelial membrane antigen, S-100 protein, or CD99. p53 staining was frequently seen in the malignant cells and was moderate to marked in degree.
The recurrent tumor consisted entirely of malignant cells intermediate to small in size (Fig. 3A) . Focally, these were seen to permeate a nerve. Their cytology varied from spindle to somewhat epithelioid (Fig. 3B) and occasionally multinucleate. Myoid markers (desmin, myogenin, myoD1) showed strong reactivity in large patches of neoplastic cells (Fig. 4A) . Strong, but actually less widespread, synaptophysin staining was also noted (Fig. 4B) . Scant CAM 5.2 and rare AE1-AE3-positive cells were seen, as was a single epithelial membrane antigen-reactive tumor cell. No recognizable epithelial structures were noted. A CD99 stain was negative. p53 immunoreactivity was moderate to strong in scattered neoplastic cells. Approximately 75% of cells were MIB-1 immunopositive. Ultrastructurally, the malignant cells included rhabdomyoblasts featuring thick and thin filaments and Z-band formation (Fig. 5A) as well as small, poorly differentiated, neuronal cells containing scant secretory granules (Fig. 5B) .
DISCUSSION
Divergent differentiation, the very essence of normal embryologic development, is a genetically determined process also seen in neoplasia. With reference to central nervous system tumors, it manifests as a subtle shift in differentiation to closely related cell types. Examples include mixed glioma (oligoastrocytoma), 14 tumors showing more substantial divergence, e.g., glioneuronal neoplasms (ganglioglioma), 12 and truly heterologous differentiation, such as gliomas exhibiting skeletal muscle, chondro-osseous, or even true epithelial differentiation. 18 Similar transitions occur in peripheral nerve tumors, both benign and malignant. Benign examples include 1) ordinary neurofibromas in which perineurial-like cells appear to arise from Schwann cells, which, based on recent genetic evidence, 20 appear to be the principle if not the only neoplastic cell, and 2) rare examples of neurofibroma with more obvious divergent differentiation. The latter include a vaginal neurofibroma containing benign skeletal muscle (benign Triton tumor), 1 an example of plexiform neurofibroma with extensive glandular differentiation, 22 and angiosarcomas arising from neurofibromas. 23 Far more often, the underlying lesion is an MPNST 6 in which embryonal rhabdomyosarcoma is the most frequently occurring element (malignant Triton tumor). 6, 25, 28 In approximately 15% of cases, the latter also feature other mesenchymal or even epithelial components (MPNST with pluridirectional differentiation). 5 Among the other mesenchymal components are chondrosarcoma, osteosarcoma, and even rare examples of angiosarcomatous elements. 23 Far less frequent than MPNST with divergent mesenchymal differentiation are examples in which epithelium of glandular, squamous, or neuroendocrine types are also present or occur alone (glandular MPNST). 6, 9, 26, 27 Interestingly, unlike the malignant mesenchymal tissues noted above, glandular components are, with rare exception, benign in appearance. 27 Of MPNSTs showing any form of divergent differentiation, an association with neurofibromatosis type 1 is seen in the majority. 6, 27, 28 Divergent differentiation in conventional schwannomas is a rare event. 21 Osseous metaplasia is often considered a secondary phenomenon superimposed upon dystrophic calcification related to hyalinized vasculature and tumor ischemia. Nonetheless, true osseous as well as cartilaginous, and even adipose, differentiation does occur in schwannomas 10, 13, 19 ; the latter is best seen as a component of psammomatous melanotic schwannoma in Carney complex. 3 Melanin production as seen in melanotic schwannomas, more often benign than malignant, is accepted as being within the repertoire of schwannian cells and is not considered divergent differentiation. The same is true of glial fibrillary acidic protein expression. 17 Although once thought to be a manifestation of glandular differentiation, 2, 5, 7, 8, 31 the finding of glands within superficially situated schwannomas is now attributed to entrapment of normal cutaneous adnexae (sweat glands replete with myoepithelial cells). 27 Thus, the spectrum of differentiation in schwannomas is largely limited to benign mesenchymal tissues. Those rare examples of angiosarcoma supervening upon schwannoma 23, 24 are thought not to represent divergent differentiation. Instead, it is considered a manifestation of intratumoral vascular stasis and malignant transformation of resident endothelial cells. 24 This interpretation is supported in part by the immunophenotypes of the two components, which differ entirely, and lack of transitional cells. Myoid differentiation has not heretofore been described in schwannoma. The same is true of bona fide neuronal transition to small cell differentiation. Although small "neuroectodermal" tumor has twice been reported, 11, 29 neither immunohistochemical (neuronal marker) staining nor diagnostic ultrastructural features (processes, microtubules, secretory granules) have been documented. Our case illustrates both. Thus, the range of differentiation, which included scant true epithelium, is truly unique.
In that conventional schwannoma differs from neurofibroma and MPNST with their varied cytologic makeup, our case brings focus upon the well-differentiated Schwann cell as the element undergoing the process of divergent differentiation. Reflecting back upon neurofibroma, the lesion underlying over half of MPNST, it may be that their so-called "perineurial-like cells" with features intermediate between Schwann and perineurial cells, having already undergone subtle divergent differentiation along perineurial lines, may be those prone to undergo further differentiation along mesenchymal and rarely glandular lines. Recent work has recognized the potential of schwannoma cells to undergo anaplasia and to form malignant epithelioid cell tumors. 29 Until now it was thought that, unlike neurofibromas, the lack of reports of metaplasia to malignant mesenchymal tissues in schwannoma reflected a basic limitation of the metaplastic potential of highly differentiated Schwann cells comprising this tumor. This would also explain why metaplastic changes in MPNST are far more frequent in those arising from neurofibromas or in patients with neurofibromatosis type 1 than in examples occurring de novo in peripheral nerves. Although the present case does not disprove this explanation, it is remarkable because it shows that malignant mesenchymal metaplasia in schwannomas can occur. Furthermore, additional evidence is provided for the role of the neoplastic Schwann cell in the formation of heterologous malignant mesenchymal and epithelial tissues in this major type of peripheral nerve sheath tumor. 
